Engaging psoriasis patients in adherence and outcomes to topical treatments: A summary from the Symposium 'Tailoring topical psoriasis treatments to patients' needs and expectations' of the 30
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
14
06
2022
accepted:
02
08
2022
entrez:
22
12
2022
pubmed:
23
12
2022
medline:
24
12
2022
Statut:
ppublish
Résumé
This article is based on a presentation given by authors at the Satellite Symposium titled 'Tailoring topical psoriasis treatments to patients' needs and expectations' held during the 30
Substances chimiques
Betamethasone
9842X06Q6M
Dermatologic Agents
0
Drug Combinations
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
9-13Subventions
Organisme : Almirall, Barcelona, Spain
Informations de copyright
© 2022 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
Références
Gelfand JM, Troxel AB, Lewis JD, Kurd SK, Shin DB, Wang X, et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol. 2007;143:1493-9.
Scottish Intercollegiate Guidelines Network. Diagnosis and management of psoriasis and psoriatic arthritis in adults. 2010. Available at: https://www.sign.ac.uk/assets/sign121.pdf. Accessed 5th April 2022.
All-Party Parliamentary Group on Skin. Mental health and skin disease. 2020. Available at: https://www.appgs.co.uk/publication/view/mental-health-and-skin-disease-2020. Accessed 5th April 2022.
Puig L, Carrascosa JM, Belinchón I, Fernández-Redondo V, Carretero G, Ruiz-Carrascosa JC, et al. Adherence and patient satisfaction with topical treatment in psoriasis, and the use, and organoleptic properties of such treatments: a Delphi study with an expert panel and members of the psoriasis Group of the Spanish Academy of dermatology and venereology. Actas Dermosifiliogr. 2013;104:488-96.
Bewley A, Page B. Maximizing patient adherence for optimal outcomes in psoriasis. J Eur Acad Dermatol Venereol. 2011;25(Suppl 4):9-14.
Chamoun A, Goudetsidis L, Poot F, Bourdeaud'hui F, Titeca G. Psoriasis and depression. Rev Med Brux. 2015;36:23-8.
Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146:891-5.
Chi C-C, Chen T-H, Wang S-H, Tung T-H. Risk of suicidality in people with psoriasis: a systematic review and meta-analysis of cohort studies. Am J Clin Dermatol. 2017;18:621-7.
Dalgard FJ, Gieler U, Tomas-Aragones L, Lien L, Poot F, Jemec GBE, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135:984-91.
Ramos VL, Van Voorhees AS. Guidelines for Management of Psoriasis: screening for comorbidities. J Dermatol Nurses Assoc. 2021;13:168-74.
Schmid-Ott G, Boehm D, Stock-Gissendanner S. Patient considerations in the management of mental stress in psoriasis. Patient Intell. 2012;4:41-50.
Rigas HM, Bucur S, Ciurduc DM, Nita IE, Constantin MM. Psychological stress and depression in psoriasis patients - a Dermatologist's perspective. Maedica (Bucur). 2019;14:287-91.
Wu B. Psychological effects of psoriasis. DermNet NZ. 2017. Available at: https://dermnetnz.org/topics/psychological-effects-of-psoriasis. Accessed 5th April 2022.
Bewley A, Barlow R, Ahmed A, Mohandas P. 19th Congress of the European Society for Dermatology and Psychiatry (ESDaP) and 2nd Brain Skin Colloquium Conference (BSC), June 11-13, 2021, London. Acta Derm Venereol. 2022;102:adv00670.
Strober BE, van der Walt JM, Armstrong AW, Bourcier M, Carvalho AVE, Chouela E, et al. Clinical goals and barriers to effective psoriasis care. Dermatol Ther (Heidelb). 2019;9:5-18.
Eliasson L, Bewley AP, Mughal F, Johnston KM, Kuznik A, Patel C, et al. Evaluation of psoriasis patients' attitudes toward benefit-risk and therapeutic trade-offs in their choice of treatments. Patient Prefer Adherence. 2017;11:353-62.
Alinia H, Moradi Tuchayi S, Smith JA, Richardson IM, Bahrami N, Jaros SC, et al. Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring. Br J Dermatol. 2017;176:759-64.
Tan X, Feldman SR, Chang J, Balkrishnan R. Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert Opin Drug Deliv. 2012;9:1263-71.
Svendsen MT, Feldman SR, Tiedemann SN, Sørensen ASS, Rivas CMR, Andersen KE. Psoriasis patient preferences for topical drugs: a systematic review. J Dermatolog Treat. 2021;32:478-83.
Florek AG, Wang CJ, Armstrong AW. Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review. Arch Dermatol Res. 2018;310:271-319.
Vasconcelos V, Teixeira A, Almeida V, Teixeira M, Ramos S, Torres T, et al. Patient preferences for attributes of topical anti-psoriatic medicines. J Dermatolog Treat. 2019;30:659-63.
Iversen L, Dauden E, Segaert S, Freeman K, Magina S, Rigopoulos D, et al. Reformulations of well-known active ingredients in the topical treatment of psoriasis vulgaris can improve clinical outcomes for patients. J Eur Acad Dermatol Venereol. 2017;31:1271-84.
Stein Gold L, Green LJ, Dhawan S, Vestbjerg B, Praestegaard M, Selmer J. A phase 3, randomized trial demonstrating the improved efficacy and patient acceptability of fixed dose calcipotriene and betamethasone dipropionate cream. J Drugs Dermatol. 2021;20:420-5.
Pinter A, Green LJ, Selmer J, Praestegaard M, Gold LS, Augustin M, et al. A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis. J Eur Acad Dermatol Venereol. 2022;36:228-36.